Anja Baumann

发表

Changes in Oral Microbial Ecology of C57BL/6 Mice at Different Ages Associated with Sampling Methodology

O. Witte, C. Frahm, Angélica Hérnandez-Arriaga, 2019, Microorganisms.

O. Witte, T. Grune, Anja Baumann, 2020, American journal of physiology. Gastrointestinal and liver physiology.

Fortifying Butterfat with Soybean Oil Attenuates the Onset of Diet-Induced Non-Alcoholic Steatohepatitis and Glucose Intolerance

Anja Baumann, I. Bergheim, C. Jin, 2021, Nutrients.

Oral Supplementation of Sodium Butyrate Attenuates the Progression of Non-Alcoholic Steatohepatitis

Anja Baumann, I. Bergheim, C. Jin, 2020, Nutrients.

Exchanging dietary fat source with extra virgin olive oil does not prevent progression of diet-induced non-alcoholic fatty liver disease and insulin resistance

Anja Baumann, I. Bergheim, C. Jin, 2020, PloS one.

Fortifying diet with rapeseed oil instead of butterfat attenuates the progression of diet-induced non-alcoholic fatty liver disease (NAFLD) and impairment of glucose tolerance.

Anja Baumann, I. Bergheim, C. Jin, 2020, Metabolism: clinical and experimental.

Consumption of decaffeinated coffee protects against the development of early non-alcoholic steatohepatitis: Role of intestinal barrier function

J. Fernandez-Checa, Anja Baumann, I. Bergheim, 2018, Redox biology.

Alterations of nitric oxide homeostasis as trigger of intestinal barrier dysfunction in non‐alcoholic fatty liver disease

M. Trauner, Anja Baumann, I. Bergheim, 2022, Journal of cellular and molecular medicine.

GW9662, a peroxisome proliferator-activated receptor gamma antagonist, attenuates the development of non-alcoholic fatty liver disease.

Anja Baumann, I. Bergheim, M. L. Pisarello, 2022, Metabolism: clinical and experimental.

Microbiota profiling in aging-associated inflammation and liver degeneration.

O. Witte, C. Frahm, T. Grune, 2021, International journal of medical microbiology : IJMM.

Oral Supplementation of Glutamine Attenuates the Progression of Nonalcoholic Steatohepatitis in C57BL/6J Mice.

Anja Baumann, I. Bergheim, C. Jin, 2017, The Journal of nutrition.

Carbon Monoxide has Antioxidative Properties in the Liver Involving p38 MAP Kinase Pathway in a Murine Model of Systemic Inflammation

N. Roewer, Anja Baumann, R. Muellenbach, 2010, Microcirculation.

Oral intake of xanthohumol attenuates lipoteichoic acid-induced inflammatory response in human PBMCs

C. Hellerbrand, Anja Baumann, I. Bergheim, 2022, European Journal of Nutrition.

Fructose, a trigger of metabolic diseases?—a narrative review

Anja Baumann, I. Bergheim, Annette Brandt, 2022, Exploration of Digestive Diseases.

Impairments of intestinal arginine and NO metabolisms trigger aging-associated intestinal barrier dysfunction and ‘inflammaging'

O. Witte, K. Wagner, B. Wessner, 2022, Redox biology.

Oral intake of xanthohumol attenuates lipoteichoic acid-induced inflammatory response in human PBMCs

C. Hellerbrand, Anja Baumann, I. Bergheim, 2022, European Journal of Nutrition.

Citrulline supplementation attenuates the development of non-alcoholic steatohepatitis in female mice through mechanisms involving intestinal arginase

Anja Baumann, I. Bergheim, A. Camarinha-Silva, 2021, Redox biology.

Moderate consumption of fermented alcoholic beverages diminishes diet-induced non-alcoholic fatty liver disease through mechanisms involving hepatic adiponectin signaling in mice

Anja Baumann, C. Jin, Annette Brandt, 2019, European Journal of Nutrition.

Metformin attenuates the onset of non-alcoholic fatty liver disease and affects intestinal microbiota and barrier in small intestine

Anja Baumann, I. Bergheim, A. Camarinha-Silva, 2019, Scientific Reports.

Metabolic Abnormalities in Normal Weight Children Are Associated with Increased Visceral Fat Accumulation, Elevated Plasma Endotoxin Levels and a Higher Monosaccharide Intake

Anja Baumann, I. Bergheim, Anika Nier, 2019, Nutrients.

Toll-like receptor 1 as a possible target in non-alcoholic fatty liver disease

J. Schattenberg, Anja Baumann, I. Bergheim, 2021, Scientific Reports.

Gw9662, a peroxisome proliferator-activated receptor gamma antagonist, attenuates the development of non-alcoholic fatty liver disease

Anja Baumann, I. Bergheim, Anika Nier, 2020, Journal of Hepatology.

Fructose: a modulator of intestinal barrier function and hepatic health?

Anja Baumann, I. Bergheim, Raphaela Staltner, 2023, European Journal of Nutrition.

Cognitive Alterations in Old Mice Are Associated with Intestinal Barrier Dysfunction and Induced Toll-like Receptor 2 and 4 Signaling in Different Brain Regions

Anja Baumann, I. Bergheim, A. Camarinha-Silva, 2023, Cells.

Supplementing L-Citrulline Can Extend Lifespan in C. elegans and Attenuate the Development of Aging-Related Impairments of Glucose Tolerance and Intestinal Barrier in Mice

Anja Baumann, A. Camarinha-Silva, Annette Brandt, 2023, Biomolecules.

Antibiotics attenuate diet-induced non-alcoholic fatty liver disease without altering intestinal barrier dysfunction.

Anja Baumann, A. Camarinha-Silva, E. Halilbasic, 2023, The Journal of nutritional biochemistry.

TNFα is a key trigger of inflammation in diet-induced non-obese MASLD in mice

Anja Baumann, I. Bergheim, Annette Brandt, 2023, Redox biology.

Carbon Monoxide has Antioxidative Properties in the Liver Involving p38 MAP Kinase Pathway in a Murine Model of Systemic Inflammation

N. Roewer, Anja Baumann, R. Muellenbach, 2010, Microcirculation.